Selected Grants
IMPALA-2 A randomized, double-blind, placebo-controlled clinical trial of once-daily inhaled molgramostim nebulizer solution in adult subjects with autoimmune pulmonary alveolar proteinosis (aPAP) SAV006-05 Site 38
Clinical TrialPrincipal Investigator · Awarded by Savara Inc. · 2021 - 2026Pneumonia LOI
Clinical TrialPrincipal Investigator · Awarded by Karius, Inc. · 2019 - 2024Pneumonia in the Immunocompromised - Use of the Karius Test for the Detection of Undiagnosed Pathogens(Pickup)
Clinical TrialPrincipal Investigator · Awarded by Karius, Inc. · 2019 - 2023VACCINE AND TREATMENT EVALUATION UNITS (VTEU) PROTOCOL DEVELOPMENT, IMPLEMENTATION AND ASSAYS TASK AREA B-D PHASE 1 PK TRIAL TO EVALUATE FOSFOMYCIN TASK ORDER 16-0058.B1C1D1.0076
ResearchResearch Specialist · Awarded by National Institutes of Health · 2017 - 2022Vaccine Trial_LOI
ResearchCo Investigator · Awarded by Universitair Medisch Centrum Utrecht · 2019 - 2021External Relationships
- Beckman Coulter, Inc.
This faculty member (or a member of their immediate family) has reported outside activities with the companies, institutions, or organizations listed above. This information is available to institutional leadership and, when appropriate, management plans are in place to address potential conflicts of interest.